SEARCH

SEARCH BY CITATION

References

  • Adinolfi, E., Melchiorri, L., Falzoni, S., Chiozzi, P., Morelli, A., Tieghi, A., Cuneo, A., Castoldi, G., Di Virgilio, F. & Baricordi, O.R. (2002) P2X7 receptor expression in evolutive and indolent forms of chronic lymphocytic leukaemia. Blood, 99, 706708.
  • Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C. & Boivin, P. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198206.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia. Blood, 94, 18401847.
  • Di Virgilio, F. & Wiley, J.S. (2002) The P2X7 receptor of CLL lymphocytes – a molecule with a split personality. Lancet, 360, 18981899.
  • Ferlini, C., Di Cesare, S., Rainaldi, G., Malorni, W., Samoggia, P., Biselli, R. & Fattorossi, A. (1996) Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry, 24, 106115.
  • Foon, K.A., Rai, K.R. & Gale, R.P. (1990) Chronic lymphocytic leukemia: new insights into biology and therapy. Annals of Internal Medicine, 113, 525539.
  • Ghia, P., Guida, G., Stella, S., Gottardi, D., Geuna, M., Strola, G., Scielzo, C. & Calligaris-Cappio, F. (2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukaemia (CLL) patients at risk of disease progression. Blood, 101, 12621269.
  • Gu, B.J., Zhang, W., Worthington, R.A., Sluyter, R., Dao-Ung, P., Petrou, S., Barden, J.A. & Wiley, J.S. (2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. Journal of Biological Chemistry, 276, 1113511142.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood, 94, 18481854.
  • Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C.M., Rae, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 33793389.
  • Kröber, A., Seiler, T., Benner, L., Bruckle, E., Lichter, P., Dohner, H. & Stilgenbauer, S. (2002) VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukaemia. Blood, 100, 14101416.
  • Miller, S.A., Dykes, D.D. & Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
  • Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., Chapman, R.M., Thomas, P.W., Copplestone, J.A., Orchard, J.A. & Hamblin, T.J. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood, 100, 11771184.
  • Pepper, C., Hoy, T. & Bentley, D.P. (1997) Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. British Journal of Cancer, 76, 935938.
  • Pepper, C., Thomas, A., Hoy, T. & Bentley, P. (1999) Chlorambucil resistance in B-cell chronic lymphocytic leukemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones. British Journal of Haematology, 104, 581588.
  • Reed, J.C. (1998) Molecular biology of chronic lymphocytic leukemia. Seminars in Oncology, 25, 1118.
  • Robertson, L.E., Plunkett, W., McConnell, K., Keating, M.J. & McDonnell, T.J. (1996) Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia, 10, 456459.
  • Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 10521057.
  • Stankovic, T., Stewart, G.S., Fegan, C., Biggs, P., Last, J., Byrd, P.J., Keenan, R.D., Moss, P.A.H. & Taylor, A.M.R. (2002) Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukaemia occurs in pregerminal centre cells and results in defective damage response and unrepaired chromosome damage. Blood, 99, 300309.
  • Thunberg, U., Tobin, G., Johnson, A., Söderberg, O., Padyukov, L., Hultdin, M., Klareskog, L., Enblad, G., Sundström, C., Roos, G. & Rosenquist, R. (2002) Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet, 360, 19351939.
  • Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 3951.
  • Wiley, J.S., Dao-Ung, L.P., Gu, B.J., Sluyter, R., Shemon, A.N., Li, C., Taper, J., Gallo, J. & Manoharan, A. (2002) A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet, 359, 11141119.